Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2075 of 6351
-
Heart disease detective: 1,000-Person study hunts for hidden genetic triggers of sudden cardiac death
Knowledge-focused Recruiting nowArrhythmogenic ventricular cardiomyopathy (AVC) is a genetic condition which affects the heart and can lead to heart failure and rhythm problems, of which, sudden cardiac arrest or death is the most tragic and dangerous. Diagnosis and screening of blood-relatives is very difficul…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
New pill shows promise for rare liver disease
Disease control CompletedThe study was a dose-ranging, 18-week study comparing two doses of HTD1801 (500 mg BID and 1000 mg BID) to placebo in adult subjects with PSC.
Phase 2 • Sponsor: HighTide Therapeutics (Hong Kong) Limited • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Nasal swab could curb unnecessary antibiotics in pneumonia
Disease control CompletedThis is a non-inferiority study evaluating clinical improvement rate when using MRSA nasal swabs to guide discontinuation of vancomycin for empiric coverage for MRSA pneumonia.
Sponsor: CAMC Health System • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Hormone drug may slow Aging-Related diseases in rare condition
Disease control CompletedBackground: DNA is a structure in the body. It contains data about how the body develops and works. Telomeres are found on the end of chromosomes in DNA. Some people with short telomeres or other gene changes can develop diseases of the bone marrow, lung, and liver. Researchers …
Phase 2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New hope for tough leukemia: Triple-Drug attack under study
Disease control OngoingThis phase Ib trial studies the side effects and best dose of navtemadlin when given together with decitabine and venetoclax in treating patients with acute myeloid leukemia that has come back after a period of improvement (recurrent), does not respond to treatment (refractory), …
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New drug combo targets tough cancers in early trial
Disease control OngoingThis phase Ib trial studies the side effects and best dose of guadecitabine and how well it works when given together with durvalumab in treating patients with liver, pancreatic, bile duct, or gallbladder cancer that has spread to other places in the body. Guadecitabine may stop …
Phase 1 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Experimental myeloma drug trial halted early
Disease control Stopped earlyThis is an open-label, multi-center, international, Phase 1/2 study to assess the safety, PK and efficacy of CC-92480 monotherapy and in combination with dexamethasone in subjects with relapsed and refractory multiple myeloma (RRMM). All eligible subjects must be previously trea…
Phase 1/2 • Sponsor: Celgene • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New drug combo shows promise for tough stomach cancers
Disease control CompletedThis phase I/II trial studies the side effects and best dose of olaparib when given together with ramucirumab and how well they work in treating patients with gastric or gastroesophageal junction cancer that has spread to other places in the body (metastatic), has come back (recu…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Can a Double-Dose vaccine strategy shield vulnerable vasculitis patients?
Disease control CompletedThe study hypothesis is that a "reinforced" pneumococcal combined vaccine strategy in patients with ANCA-associated vasculitides treated with rituximab will induce a better immune response than the current standard regimen, with an acceptable safety profile. This study therefore…
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Could simple education tame myeloma Treatment's harsh side effects?
Symptom relief CompletedThis study evaluated an individualized, nurse-delivered education program for managing treatment-related symptoms in patients with newly diagnosed multiple myeloma receiving bortezomib for the first time. A total of 40 patients participated. Twenty patients received two individua…
Sponsor: Can Lafci • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
Can VR goggles tame sickle cell pain? new trial aims to find out
Symptom relief Recruiting nowAcute vaso-occlusive crisis (VOC) is the most common complication in patients with sickle cell disease (SCD) and pain related to VOC is often inadequately treated. This is a phase II randomized controlled clinical trial evaluating the efficacy of virtual reality technology when a…
Sponsor: St. Jude Children's Research Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Can young blood reverse aging? new trial tests monthly plasma transfusions
Disease control By invitation only1. Primary Objective To determine the safety and tolerability of 12 once monthly transfusions of GMFFP (Granulocyte - Colony Stimulating Factor (G-CSF) Mobilized Fresh Frozen Plasma harvested from young, healthy donors), given to older, frail individuals who are at risk due t…
Phase 1/2 • Sponsor: Dipnarine Maharaj • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Immune cocktail shows promise in early trial for stubborn cancers
Disease control CompletedBackground: The drug Interleukin-15 (IL-15) activates the immune system. The drugs nivolumab and ipilimumab unblock immune cells. The drugs together may allow immune cells to recognize and attack cancer cells, causing tumors to shrink. Objective: To test the effects and maximu…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Kidney failure patients may ditch immune drugs in landmark trial
Disease control OngoingThis prospective randomized trial aims to evaluate the feasibility, risk and benefit of the discontinuation of immunosuppressive maintenance treatments in AAV (Antineutrophil Cytoplasmic Autoantibodies (ANCA)-associated vasculitis) patients who have reached ESRD (end-stage renal …
Phase 3 • Sponsor: Centre Hospitalier Departemental Vendee • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Half-Matched hope: new stem cell approach for sickle cell disease enters human testing
Disease control Recruiting nowThis is a study to evaluate the safety and toxicity of a treatment regimen consisting of 2 cycles of pre-transplant immunosuppressive therapy followed by myeloablative preparative regimen and allogeneic hematopoietic stem cell transplantation from a haploidentical donor in patien…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Old drug, new hope: lithium tested to stop Alzheimer's before it starts
Prevention CompletedAlzheimer's disease (AD) is the most common cause of dementia in adults 65 years and older. AD leads to a complete loss of memory and independent function, and presently there is no cure. Many studies suggest that lithium treatment may delay dementia onset or slow its progression…
Phase 4 • Sponsor: Ariel Gildengers, MD • Aim: Prevention
Last updated Jun 26, 2026 15:58 UTC
-
Can a lenticule implant clear cloudy corneas from viral infection?
Disease control OngoingAdenoviral keratitis(caused by adenovirus) is one of the most frequently diagnosed eye diseases. Most of these infections have symptoms like (Ocular itchiness and irritation, chemosis (conjunctival edema),photophobia, epiphora, foreign body sensation, epithelial keratitis etc.Ade…
Sponsor: Eye Hospital Pristina Kosovo • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
A slice of donor cornea may patch thinning eyes — a trial puts it to the test
Disease control By invitation onlyStroma is a fibrous, tough, transparent and the thickest layer of the corneae. The stroma is composed of organised collagen, which maintains transparency. Keratocytes are located between the lamella collagen fibers and secrete an extracellular matrix, which includes collagen, pro…
Sponsor: Eye Hospital Pristina Kosovo • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Leg workouts may unlock a hidden cause of exercise intolerance in common heart failure
Disease control PausedHeart failure with preserved ejection fraction (HFpEF) accounts for approximately half of the heart failure population in the United States. The primary chronic symptom in patients with HFpEF is severe exercise intolerance quantified as reduced peak oxygen uptake during whole bod…
Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Sweet relief? candy and honey may shield salivary glands from radiation damage
Symptom relief CompletedThe purpose of this study is to determine whether the use of honey mouthwashes in the prevention of salivary side effects of 131I (radioiodine) therapy.
Sponsor: Cyprus University of Technology • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC